The effect of interferon alpha and prednisolone on the serum concentrations of the aminoterminal domain of procollagen type III(PIIIP) and type IV (7-S collagen) in patients with chronic hepatitis B
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 19 (1) , 36-42
- https://doi.org/10.1016/s0168-8278(05)80173-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Steroid treatment lowers hepatic fibroplasia, as explored by serum aminoterminal procollagen III peptide, in chronic liver diseaseLiver International, 2008
- Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesisJournal of Hepatology, 1991
- Hepatic Fibrosis — New Therapeutic ApproachesNew England Journal of Medicine, 1991
- Hepatic Fibrosis and Its Serum Markers: A ReviewDigestive Diseases, 1991
- Interferons and Collagen ProductionJournal of Investigative Dermatology, 1990
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Therapy for Hepatic FibrosisSeminars in Liver Disease, 1990
- The biological basis for clinical use of interferonJournal of Hepatology, 1990
- γ–Interferon Treatment Inhibits Collagen Deposition in Murine SchistosomiasisHepatology, 1989
- Blood analysis for liver fibrosisJournal of Hepatology, 1985